𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potential role for the common cystic fibrosis ΔF508 mutation in Crohn's disease

✍ Scribed by Francesca Bresso; Johan Askling; Marco Astegiano; Brunello Demarchi; Nicoletta Sapone; Mario Rizzetto; Paolo Gionchetti; Karen M. Lammers; Annalisa de Leone; Gabriele Riegler; Elaine R. Nimmo; Hazel Drummond; Colin Noble; Leif Torkvist; Anders Ekbom; Marco Zucchelli; Robert Lofberg; Jack Satsangi; Sven Pettersson; Mauro D'Amato

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
92 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Inflammatory bowel disease (ibd) is an epithelial barrier disease that is thought to result from a dysregulated interaction with bacteria in the intestine of genetically predisposed individuals. the cystic fibrosis transmembrane conductance regulator (cftr), which is mutated in the autosomal recessive disease cystic fibrosis, modulates gut permeability, mucus production, and epithelial interactions with bacteria. the cystic fibrosis deltaf508 mutation is commonly found in the general population and has been shown to result in a reduced number of cftr molecules at the surface of epithelial cells. given the important biological functions of cftr in the intestine, we tested whether this mutation is of relevance to ibd.

Methods:

Using dna heteroduplex analysis, we investigated the distribution of deltaf508 heterozygosity in 2568 subjects from three independent cohorts of italian, swedish, and scottish ibd patients and controls.

Results:

In all three cohorts an association between deltaf508 and crohn's disease (cd) was observed. specifically, deltaf508 heterozygosity was markedly underrepresented in cd patients from italy and sweden (p = 0.021 and 0.027 versus controls, respectively), while stratification for disease location revealed an absence of deltaf508 carriers among scottish cd patients with right-sided colitis (p = 0.023 versus all other locations).

Conclusions:

Deltaf508 heterozygosity might exert a protective effect in cd.

📜 SIMILAR VOLUMES

ΔF508 cystic fibrosis mutation appears v
ΔF508 cystic fibrosis mutation appears very infrequently in the Greek-Cypriot community of Cyprus
✍ C. D. Constantinou-Deltas; Christina Georgiou; Panos Ioannou; Michael Angastinio 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Cystic fibrosis (CF) is an autosomal recessive disorder which is considered to be the most frequent genetic disorder in the Caucasian population. In a large number of populations tested it is found in an average frequency of 1 CF chromosome per 25 individuals, resulting in a patient frequency of 1:2

Population screening if F508del (ΔF508),
Population screening if F508del (ΔF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina
✍ María Roqué; Clara Pott Godoy; Mariana Castellanos; Eduardo Pusiol; Luis S. Mayo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

Cystic fibrosis (CF) is the most common autosomal recessive disease in the Caucasian population. The disease can be caused by one of the more than 900 different mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. However, the deletion of the phe508-codon is the most pre

Cystic fibrosis patients with mutation 1
Cystic fibrosis patients with mutation 1949del84 in exon 13 of the CFTR gene have a similar clinical severity as ΔF508 homozygotes
✍ V. Nunes; T. Casals; A. Gaona; G. Antiñolo; J. Ferrer-Calvete; J. Pérez-Frias; E 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

The majority of the identified cystic fibrosis (CF) mutations are very uncommon in the total patient population, making the correlation between the clinical presentation and the molecular alterations difficult. The largest deletion that has been described so far in C F is of 84 bp in exon 13, which

Assessment of the reliability of single
Assessment of the reliability of single blastomere analysis for preimplantation diagnosis of the ΔF508 deletion causing cystic fibrosis in clinical practice
✍ Pierre F. Ray; Asangla Ao; Deborah M. Taylor; Robert M. L. Winston; Alan H. Hand 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views

Following the birth of a baby girl confirmed to be homozygous normal for the delta F508 deletion causing cystic fibrosis (CF), many single-gene defects have been diagnosed by polymerase chain reaction (PCR) for preimplantation genetic diagnosis (PGD). A few misdiagnoses have been reported but no lar